Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urologic Diseases 1Shock 1Rheumatic Diseases 1Renal Insufficiency 1Nervous System Diseases 1Kidney Diseases 1Infections 1Hematologic Diseases 1Heart Failure 1Gastrointestinal Diseases 1Critical Illness 1Cardiovascular Diseases 1Asthma 1Arrhythmias, Cardiac 1

Interventions

Dexamethasone 8Bortezomib 7Cyclophosphamide 6Lenalidomide 4isatuximab 3glucarpidase 3Calcium Dobesilate 3Thalidomide 2Kidney Transplantation 2Blood Specimen Collection 2Bendamustine Hydrochloride 2pomalidomide 1gamma-Glutamyl Hydrolase 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Whole-Body Irradiation 1Urination 1Urinalysis 1Stents 1Standard of Care 1Rituximab 1Ranitidine 1Nephrotomy 1Nephrostomy, Percutaneous 1Methotrexate 1Leucovorin 1Ice 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Renal Insufficiency × Health Information Exchange × Clear all
NCT05443321 2026-01-23

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

Brigham and Women's Hospital

Phase NA Enrolling by invitation
1,006 enrolled
GastrointestinalGenitourinary

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡